The effect of COVID-19 on development of hair and nail disorders: a Turkish multicenter, controlled study

dc.authoridOguz, Isil Deniz/0000-0001-8628-6107
dc.authoridKULAKLI, SEVGI/0000-0001-7886-1060
dc.authoridTurkmen, Dursun/0000-0001-9076-4669
dc.authoridKulcu Cakmak, Seray/0000-0001-8536-5946
dc.authoridOZKESICI KURT, Birgul/0000-0003-3121-5816
dc.authoridKaya Ozden, Hatice/0000-0003-0203-272X
dc.authoridTosun, Mustafa/0000-0002-6189-8016
dc.contributor.authorKutlu, Omer
dc.contributor.authorDemircan, Yuhanize Tas
dc.contributor.authorYildiz, Kenan
dc.contributor.authorKalkan, Goknur
dc.contributor.authorDemirseren, Duriye Deniz
dc.contributor.authorAn, Isa
dc.contributor.authorOba, Muazzez Cigdem
dc.date.accessioned2024-10-26T18:11:46Z
dc.date.available2024-10-26T18:11:46Z
dc.date.issued2023
dc.departmentSivas Cumhuriyet Üniversitesi
dc.description.abstractBackground A broad spectrum of skin diseases, including hair and nails, can be directly or indirectly triggered by COVID-19. It is aimed to examine the type and frequency of hair and nail disorders after COVID-19 infection. Methods This is a multicenter study conducted on consecutive 2171 post-COVID-19 patients. Patients who developed hair and nail disorders and did not develop hair and nail disorders were recruited as subject and control groups. The type and frequency of hair and nail disorders were examined. Results The rate of the previous admission in hospital due to COVID-19 was statistically significantly more common in patients who developed hair loss after getting infected with COVID-19 (P < 0.001). Telogen effluvium (85%) was the most common hair loss type followed by worsening of androgenetic alopecia (7%) after COVID-19 infection. The mean stress scores during and after getting infected with COVID-19 were 6.88 +/- 2.77 and 3.64 +/- 3.04, respectively, in the hair loss group and were 5.77 +/- 3.18 and 2.81 +/- 2.84, respectively, in the control group (P < 0.001, P < 0.001). The frequency of recurrent COVID-19 was statistically significantly higher in men with severe androgenetic alopecia (Grades 4-7 HNS) (P = 0.012; Odds ratio: 2.931 [1.222-7.027]). The most common nail disorders were leukonychia, onycholysis, Beau's lines, onychomadesis, and onychoschisis, respectively. The symptoms of COVID-19 were statistically significantly more common in patients having nail disorders after getting infected with COVID-19 when compared to the control group (P < 0.05). Conclusion The development of both nail and hair disorders after COVID-19 seems to be related to a history of severe COVID-19.
dc.identifier.doi10.1111/ijd.16454
dc.identifier.endpage211
dc.identifier.issn0011-9059
dc.identifier.issn1365-4632
dc.identifier.issue2
dc.identifier.pmid36281828
dc.identifier.scopus2-s2.0-85140408930
dc.identifier.scopusqualityQ2
dc.identifier.startpage202
dc.identifier.urihttps://doi.org/10.1111/ijd.16454
dc.identifier.urihttps://hdl.handle.net/20.500.12418/30814
dc.identifier.volume62
dc.identifier.wosWOS:000871413000001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofInternational Journal of Dermatology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleThe effect of COVID-19 on development of hair and nail disorders: a Turkish multicenter, controlled study
dc.typeArticle

Dosyalar